1. Home
  2. OPRX vs STXS Comparison

OPRX vs STXS Comparison

Compare OPRX & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPRX
  • STXS
  • Stock Information
  • Founded
  • OPRX 2006
  • STXS 1990
  • Country
  • OPRX United States
  • STXS United States
  • Employees
  • OPRX N/A
  • STXS N/A
  • Industry
  • OPRX Business Services
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • OPRX Consumer Discretionary
  • STXS Health Care
  • Exchange
  • OPRX Nasdaq
  • STXS Nasdaq
  • Market Cap
  • OPRX 154.9M
  • STXS 151.3M
  • IPO Year
  • OPRX N/A
  • STXS 2004
  • Fundamental
  • Price
  • OPRX $9.91
  • STXS $2.18
  • Analyst Decision
  • OPRX Buy
  • STXS
  • Analyst Count
  • OPRX 8
  • STXS 0
  • Target Price
  • OPRX $9.06
  • STXS N/A
  • AVG Volume (30 Days)
  • OPRX 155.8K
  • STXS 285.8K
  • Earning Date
  • OPRX 05-12-2025
  • STXS 05-12-2025
  • Dividend Yield
  • OPRX N/A
  • STXS N/A
  • EPS Growth
  • OPRX N/A
  • STXS N/A
  • EPS
  • OPRX N/A
  • STXS N/A
  • Revenue
  • OPRX $92,127,000.00
  • STXS $26,918,000.00
  • Revenue This Year
  • OPRX $12.12
  • STXS $25.90
  • Revenue Next Year
  • OPRX $10.87
  • STXS $60.57
  • P/E Ratio
  • OPRX N/A
  • STXS N/A
  • Revenue Growth
  • OPRX 28.81
  • STXS 0.55
  • 52 Week Low
  • OPRX $3.78
  • STXS $1.54
  • 52 Week High
  • OPRX $14.13
  • STXS $2.72
  • Technical
  • Relative Strength Index (RSI)
  • OPRX 66.01
  • STXS 66.61
  • Support Level
  • OPRX $9.12
  • STXS $1.93
  • Resistance Level
  • OPRX $10.38
  • STXS $2.07
  • Average True Range (ATR)
  • OPRX 0.65
  • STXS 0.09
  • MACD
  • OPRX 0.06
  • STXS 0.03
  • Stochastic Oscillator
  • OPRX 78.79
  • STXS 94.05

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: